1304 Robust machine learning (ML) approach for screening microbiome ecosystem therapies (MET) drug candidates in combination with immune checkpoint inhibitors

• Emmanuel Prestat,
• Elsa Schalck,
• Antoine Bonnefoy,
• Antoine Sabourin,
• Cyrielle Gasc,
• Carole Schwintner,
• Nathalie Corvaia

Affiliations

Emmanuel Prestat

1MaaT Pharma, Lyon, France

Elsa Schalck

2Euranova, Marseille, France

Antoine Bonnefoy

2Euranova, Marseille, France

Antoine Sabourin

1MaaT Pharma, Lyon, France

Cyrielle Gasc

1MaaT Pharma, Lyon, France

Carole Schwintner

1MaaT Pharma, Lyon, France

Nathalie Corvaia

1MaaT Pharma, Lyon, France